Abstract Library

#1923 Metastatic Pancreatic Neuroendocrine Tumors (pNETs) and Primary Tumor Resection: A NCDB Survival Evaluation

Introduction: The role of surgical resection of primary and non-primary site tumors in pNETs is still debated.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Westin G

Authors: Westin G, Alsidawi S, Hobday T, Halfdanarson T,

Keywords: PNET, Metastatic, carcinoid, NCDB,

#1868 Study Protocol: Prospective, Randomized Controlled Trial on the Effect of Primary Resection in Advanced Metastatic NEN of Pancreas and Midgut (PRESNENAS)

Introduction: The role of Primary Tumor resection in advanced metastatic NEN is discussed controversely.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Begum N

Authors: Begum N, Pavel M, Goretzki P, Vonthein R,

Keywords: Prospective Randomized, Controlled Trial, Surgery, Role of Primary Resection,

#1827 Primary Tumor Resection Results in Superior Overall Survival after Peptide Receptor Radionuclide Therapy in Advanced Neuroendocrine Neoplasms

Introduction: Peptide receptor radionuclide therapy (PRRT) is an highly effective therapeutic option to treat advanced neuroendocrine neoplasms (NEN). However, it is still unclear whether resection of primary tumors improves overall survival (OS) after PRRT.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Kaemmerer D

Authors: Kaemmerer D, Twrznik M, Hommann M, Hörsch D, Baum R,

Keywords: PRRT, surgery,

#1748 External Validation of Prognostic Classification Score for Predicting Overall Survival (OS) of Patients (pts) with Advanced Well Differentiated Neuroendocrine Tumour (WDNET). Neuroendocrine European Prognostic Score (NEP Score Working Group)

Introduction: Absence of relevant prognostic score (PS) in NET

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Pusceddu S

Authors: Pusceddu S, Barretta F, Botta L, Trama A, Milione M,

Keywords: neuroendocrine, prognostic score,

#1602 Systematic Review of Resecting Primary Tumor in MNETs Patients with Unresectable Liver Metastases

Introduction: Treatment for midgut neuroendocrine tumors (MNETS) with unresectable liver metastasis has long been a controversial issue.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Zhao H

Authors: Guo J, Bi X, Zhou J, Li Z, Huang Z,

Keywords: midgut neuroendocrine tumor, liver metastasis, primary tumor resection,